CELLECTIS S A's ticker is CLLS and the CUSIP is 15117K103. A total of 79 filers reported holding CELLECTIS S A in Q2 2021. The put-call ratio across all filers is 1.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,302,844 | +1.9% | 2,186,960 | 0.0% | 0.12% | +6.4% |
| Q1 2023 | $4,220,833 | +250.3% | 2,186,960 | +413.7% | 0.11% | +142.2% |
| Q2 2022 | $1,205,000 | -37.7% | 425,726 | 0.0% | 0.04% | -16.7% |
| Q1 2022 | $1,933,000 | -44.1% | 425,726 | 0.0% | 0.05% | -34.1% |
| Q4 2021 | $3,457,000 | -35.6% | 425,726 | 0.0% | 0.08% | -33.3% |
| Q3 2021 | $5,368,000 | -18.5% | 425,726 | 0.0% | 0.12% | -15.8% |
| Q2 2021 | $6,586,000 | -23.5% | 425,726 | 0.0% | 0.15% | -32.7% |
| Q1 2021 | $8,604,000 | -25.3% | 425,726 | 0.0% | 0.22% | -89.6% |
| Q4 2020 | $11,520,000 | +46.3% | 425,726 | 0.0% | 2.09% | -7.5% |
| Q3 2020 | $7,876,000 | – | 425,726 | – | 2.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Long Focus Capital Management, LLC | 4,487,293 | $7,089,923 | 0.25% |
| OPPENHEIMER & CO INC | 121,420 | $191,844 | 0.00% |
| CREDIT SUISSE AG/ | 1,438,255 | $2,272,443 | 0.00% |
| Baillie Gifford | 1,164,009 | $1,839,135 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 656,600 | $1,037,428 | 0.00% |
| Capital International Investors | 1,848,804 | $2,921,110 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,095,966 | $1,731,626 | 0.00% |
| EverSource Wealth Advisors, LLC | 13 | $21 | 0.00% |
| Qube Research & Technologies Ltd | 40 | $63 | 0.00% |
| Tower Research Capital LLC (TRC) | 111 | $175 | 0.00% |